EWPI Stock Overview
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Emerging World Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | -99.99% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| EWPI | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | n/a | 10.6% | 21.9% |
Return vs Industry: Insufficient data to determine how EWPI performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how EWPI performed against the US Market.
Price Volatility
| EWPI volatility | |
|---|---|
| EWPI Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EWPI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EWPI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | n/a | n/a |
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. It provides production infrastructure, hiring and training of local employees, and raw materials to these companies. The company focuses its investments on pharmaceutical companies that have contracts with church and other non government organizations, government, and wholesalers.
Emerging World Pharma, Inc. Fundamentals Summary
| EWPI fundamental statistics | |
|---|---|
| Market cap | US$119.00 |
| Earnings (TTM) | -US$219.24k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs EWPI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EWPI income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$219.24k |
| Earnings | -US$219.24k |
Last Reported Earnings
Sep 30, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EWPI perform over the long term?
See historical performance and comparison